Lisa M. Smits

6, Avenue Du Swing
Belvaux, ES L4367, Luxembourg

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression.

Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression.

Journal: American journal of human genetics

Published: June 14, 2021

Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment.

Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: May 04, 2021

Monitoring the neurotransmitter release of human midbrain organoids using a redox cycling microsensor as a novel tool for personalized Parkinson's disease modelling and drug screening.

Monitoring the neurotransmitter release of human midbrain organoids using a redox cycling microsensor as a novel tool for personalized Parkinson's disease modelling and drug screening.

Journal: The Analyst

Published: February 24, 2021

Machine learning-assisted neurotoxicity prediction in human midbrain organoids.

Machine learning-assisted neurotoxicity prediction in human midbrain organoids.

Journal: Parkinsonism & related disorders

Published: February 03, 2020

Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoids.

Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoids.

Journal: Cell and tissue research

Published: January 23, 2020

Midbrain Organoids: A New Tool to Investigate Parkinson's Disease.

Midbrain Organoids: A New Tool to Investigate Parkinson's Disease.

Journal: Frontiers in cell and developmental biology

Published: November 30, 2019

The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1.

The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1.

Journal: Cell reports

Published: December 06, 2018

Modeling Parkinson's disease in midbrain-like organoids.

Modeling Parkinson's disease in midbrain-like organoids.

Journal: NPJ Parkinson's disease

Published: August 06, 2018

Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity.

Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity.

Journal: Acta neuropathologica communications

Published: May 06, 2018

Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.

Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 29, 2017

Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.

Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.

Journal: Stem cell reports

Published: July 01, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026